세계의 요천추 신경근 통증 시장 보고서(2025년)
Lumbosacral Radicular Pain Global Market Report 2025
상품코드 : 1769644
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

요천추 신경근 통증 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간 동안의 성장 전망은 통증 관리 기술의 발전, 비오피오이드 치료 옵션에 대한 강조 증가, 척추 연구 및 개발에 대한 투자 확대, 외래 및 최소 침습적 시술에 대한 수요 증가, 신흥 시장에서의 의료 접근성 개선 등에 기인합니다. 이 기간 동안 예상되는 주요 동향으로는 최소 침습 수술 기술의 발전, 표적 항염증제 개발, 웨어러블 통증 관리 기기의 혁신, 신경근을 식별하기 위한 첨단 영상 방법, 환자별 데이터에 기반한 개인 맞춤형 치료 계획의 수립 등이 있습니다.

퇴행성 척추 질환의 유병률이 증가함에 따라 앞으로 몇 년 동안 요추부 신경근 통증 시장이 성장할 것으로 예상됩니다. 퇴행성 척추 질환은 시간이 지남에 따라 척추가 점진적으로 악화되어 발생하는 다양한 질환을 포함합니다. 이러한 증가는 주로 인구 고령화와 척추 퇴행 및 신경 압박에 기여하는 생활 습관 요인에 의해 촉진되며, 이로 인해 효과적인 진단 및 치료에 대한 수요가 증가하고 있습니다. 요추부 신경근 통증은 신경근의 자극이나 압박을 강조하여 근본적인 퇴행성 척추 문제를 나타내는 지표로 작용하여 임상 평가 및 치료 계획에 도움이 됩니다. 예를 들어, 2023년 5월, 호주에 있는 공립 대학인 시드니 대학은 2050년까지 전 세계적으로 8억 명 이상의 사람들이 요통을 경험할 것으로 전망했습니다. 그 결과, 퇴행성 척추 질환의 발병률이 증가하는 것이 요추부 신경근 통증 시장의 확장을 촉진하는 주요 요인이 되고 있습니다.

요천추 신경근 통증 시장 선도 기업들은 통증 완화와 환자 편의성을 향상시키기 위해 소형화되고 재충전 가능한 척수 자극(SCS) 시스템 등 고급 최소 침습적 신경 조절 치료법 개발을 우선순위로 두고 있습니다. 이러한 소형화 된 SCS 장치는 척수에 전기적 충격을 전달하여 통증 신호를 차단하며, 장시간 배터리 수명과 덜 침습적인 치료 옵션을 제공합니다. 예를 들어, 2022년 12월 미국 기반 의료 기업인 Abbott Laboratories는 만성 통증 관리용 고급 BurstDR 치료를 제공하는 Eterna 척추 자극 시스템을 출시했습니다. 이 시스템은 충전 사이의 시간을 크게 연장해 환자의 불편을 줄이는 최신 재충전식 배터리 기술을 특징으로 합니다. 또한 자연스러운 신경 활동을 모방해 더 효과적이고 지속적인 통증 완화를 제공하는 독점적 자극 패턴인 BurstDR을 포함합니다. 이 장치는 MRI 호환이 가능해 환자가 장치를 제거하지 않고 전신 스캔을 안전하게 받을 수 있습니다. 또한 디자인이 업그레이드 친화적이어서 환자가 추가 수술 없이 미래 기술 개선을 이용할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Lumbosacral radicular pain is a type of pain that begins in the lower spine (lumbar and sacral areas) and travels along the course of a spinal nerve into the leg. It is most often caused by compression or irritation of the nerve root, typically resulting from conditions like a herniated disc or spinal stenosis.

The primary categories of treatment for lumbosacral radicular pain include pharmacological therapies, non-pharmacological approaches, and interventional procedures. Pharmacological therapies involve the use of drugs or medications to diagnose, manage, or prevent health conditions. These medications can be administered through various methods, including oral, topical, injectable, and implantable routes. The distribution of these drugs occurs through different channels such as hospital pharmacies, retail pharmacies, and online pharmacies, serving a range of end-users including hospitals, specialty clinics, rehabilitation centers, and homecare environments.

The lumbosacral radicular pain market research report is one of a series of new reports from The Business Research Company that provides lumbosacral radicular pain market statistics, including the lumbosacral radicular pain industry global market size, regional shares, competitors with the lumbosacral radicular pain market share, detailed lumbosacral radicular pain market segments, market trends, and opportunities, and any further data you may need to thrive in the lumbosacral radicular pain industry. This lumbosacral radicular pain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lumbosacral radicular pain market size has grown strongly in recent years. It will grow from $0.91 billion in 2024 to $0.97 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth during the historic period can be credited to the rising prevalence of lower back disorders, a growing elderly population experiencing spinal problems, an increase in sedentary lifestyles and poor posture, heightened demand for pain management treatments, and greater awareness regarding early diagnosis and intervention.

The lumbosacral radicular pain market size is expected to see strong growth in the next few years. It will grow to $1.21 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The projected growth in the forecast period can be attributed to advancements in pain management technologies, a growing emphasis on non-opioid treatment alternatives, increased investment in spinal research and development, rising demand for outpatient and minimally invasive procedures, and improved access to healthcare in emerging markets. Key trends expected during this period include progress in minimally invasive surgical techniques, the development of targeted anti-inflammatory medications, innovations in wearable pain management devices, advanced imaging methods for identifying nerve roots, and the creation of personalized treatment plans based on patient-specific data.

The rising prevalence of degenerative spinal conditions is anticipated to drive the growth of the lumbosacral radicular pain market in the coming years. Degenerative spinal conditions encompass a range of disorders resulting from the progressive deterioration of the spine over time. This increase is primarily driven by aging populations and lifestyle factors that contribute to spinal degeneration and nerve compression, leading to greater demand for effective diagnosis and treatment. Lumbosacral radicular pain serves as an indicator of underlying degenerative spinal issues by highlighting nerve root irritation or compression, thereby aiding clinical assessment and treatment planning. For example, in May 2023, the University of Sydney, an Australia-based public university, projected that over 800 million people globally will experience back pain by 2050. As a result, the growing incidence of degenerative spinal conditions is a key factor fueling the expansion of the lumbosacral radicular pain market.

Leading companies in the lumbosacral radicular pain market are prioritizing the development of advanced minimally invasive neuromodulation therapies, including compact and rechargeable spinal cord stimulation (SCS) systems, to improve pain relief and enhance patient comfort. These miniaturized SCS devices are implantable and deliver electrical impulses to the spinal cord to disrupt pain signals, providing extended battery life and less invasive treatment options. For example, in December 2022, Abbott Laboratories, a U.S.-based healthcare company, introduced the Eterna spinal cord stimulation system designed to deliver advanced BurstDR therapy for chronic pain management. This system features state-of-the-art rechargeable battery technology that significantly lengthens the time between recharges, reducing inconvenience for patients. It also includes proprietary stimulation patterns, such as BurstDR, that replicate natural nerve activity for more effective and sustained pain relief. Additionally, the device is MRI-compatible, allowing patients to safely undergo full-body scans without device removal. Its design is also upgrade-friendly, enabling patients to access future technological improvements without requiring further surgeries.

In October 2024, Stryker Corporation, a U.S.-based medical technology company, acquired Vertos Medical Inc. for an undisclosed sum. This acquisition is intended to bolster Stryker's portfolio of minimally invasive spine treatments by incorporating Vertos Medical's innovative technologies, improving patient outcomes, and reinforcing its position as a leader in the spinal health market. Vertos Medical Inc. is a U.S.-based company focused on minimally invasive treatments for lumbar spinal stenosis (LSS).

Major players in the lumbosacral radicular pain market are Pfizer Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Eli Lilly and Company, Boston Scientific Corporation, Vertex Pharmaceuticals, Biotronik, Nevro Corp., Sorrento Therapeutics, Scilex Holding Company, ProMed Pharma, SPR Therapeutics, Saluda Medical Pty Ltd., Eliem Therapeutics, Cephalon Inc., Semnur Pharmaceuticals Inc., Nalu Medical Inc., Sollis Therapeutics Inc.

North America was the largest region in the lumbosacral radicular pain market in 2024. The regions covered in lumbosacral radicular pain report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lumbosacral radicular pain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lumbosacral radicular pain market includes revenues earned by entities by providing services such as non-surgical treatment services, interventional pain management services, and rehabilitation and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lumbosacral Radicular Pain Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lumbosacral radicular pain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for lumbosacral radicular pain ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lumbosacral radicular pain market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Lumbosacral Radicular Pain Market Characteristics

3. Lumbosacral Radicular Pain Market Trends And Strategies

4. Lumbosacral Radicular Pain Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lumbosacral Radicular Pain Growth Analysis And Strategic Analysis Framework

6. Lumbosacral Radicular Pain Market Segmentation

7. Lumbosacral Radicular Pain Market Regional And Country Analysis

8. Asia-Pacific Lumbosacral Radicular Pain Market

9. China Lumbosacral Radicular Pain Market

10. India Lumbosacral Radicular Pain Market

11. Japan Lumbosacral Radicular Pain Market

12. Australia Lumbosacral Radicular Pain Market

13. Indonesia Lumbosacral Radicular Pain Market

14. South Korea Lumbosacral Radicular Pain Market

15. Western Europe Lumbosacral Radicular Pain Market

16. UK Lumbosacral Radicular Pain Market

17. Germany Lumbosacral Radicular Pain Market

18. France Lumbosacral Radicular Pain Market

19. Italy Lumbosacral Radicular Pain Market

20. Spain Lumbosacral Radicular Pain Market

21. Eastern Europe Lumbosacral Radicular Pain Market

22. Russia Lumbosacral Radicular Pain Market

23. North America Lumbosacral Radicular Pain Market

24. USA Lumbosacral Radicular Pain Market

25. Canada Lumbosacral Radicular Pain Market

26. South America Lumbosacral Radicular Pain Market

27. Brazil Lumbosacral Radicular Pain Market

28. Middle East Lumbosacral Radicular Pain Market

29. Africa Lumbosacral Radicular Pain Market

30. Lumbosacral Radicular Pain Market Competitive Landscape And Company Profiles

31. Lumbosacral Radicular Pain Market Other Major And Innovative Companies

32. Global Lumbosacral Radicular Pain Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lumbosacral Radicular Pain Market

34. Recent Developments In The Lumbosacral Radicular Pain Market

35. Lumbosacral Radicular Pain Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기